Cost per reportable result coagulation analyzer at naval hospital twentynine palms
Ended Awarded Last action
- Contract number
- HT941024F0143
- Awardee
-
Werfen USA LLC UEI JA87HT8KP2M2
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $50,490
Award facts
- Contract value 100% obligated
- $50,489.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Bedford, MA 01730, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Original award | $50,490 |
About this award
The Defense Health Agency awarded a $50,489.84 delivery order to Werfen USA LLC on September 28, 2024, for the provision of two ACL Elite Pro coagulation analyzers and associated reagents to support cost-per-reportable-result testing at Naval Hospital Twentynine Palms. The award is structured as a firm fixed-price contract with an ultimate completion date of August 31, 2025, and is issued under the Critical Analyzers, Laboratory GSA Schedule (FSS-66-III). No set-aside designation was applied to this procurement. Werfen USA LLC, a Bedford, Massachusetts-based manufacturer of in vitro diagnostic equipment and clinical laboratory instrumentation, serves as the prime contractor and will perform the work from its Massachusetts location.
This delivery order is issued against Werfen's larger indefinite delivery vehicle contracts with the Defense Health Agency, which leverage the company's extensive portfolio of coagulation testing and analyzer supply agreements across federal healthcare systems. Werfen maintains significant market presence within the Department of Veterans Affairs and Defense Health Agency for automated diagnostic testing platforms, with prior awards including multi-million-dollar blanket purchase agreements and indefinite delivery contracts. The provision of coagulation analyzers and reagents on a cost-per-reportable-result basis represents a standard service delivery model utilized across federal medical treatment facilities to optimize laboratory testing capabilities while controlling operational expenses.
Quick answers
Who was awarded contract HT941024F0143?
HT941024F0143 was awarded to Werfen USA LLC by Defense Health Agency (Department of Defense) on September 28, 2024.
How much is contract HT941024F0143 worth?
The government has obligated $50,490 on HT941024F0143.
Is contract HT941024F0143 an order under another contract?
Yes. HT941024F0143 is a delivery order under V797D30108, a federal supply schedule, on Critical Analyzers, Laboratory (FSS-66-III).
Was contract HT941024F0143 competed?
The extent of competition for HT941024F0143 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award